ARCHIVES

FDA’s Oncologic Drugs Advisory Committee recommended approval of three drugs for cancer, voted down one.

This article is from The Cancer Letter archive.

Vol. 31 No. 33 | September 16, 2005

Download PDF Visit The Full Archive

Related Articles

In Brief: Georgetown Professor Heads Cancer Therapy Evaluation Program; NCI-VA Branch Abolished

September 7, 1979

Cancer “Report Card”: Growing Population Of Cancer Survivors Creates Need For New Research Emphasis, NCI Director Says

March 20, 1998

NCI Intramural Budget: Well-Funded Labs, High Costs, Or Deceiving Appearances?

April 21, 1995

Charles Sawyers to be New AACR President-Elect

March 23, 2012

O’Neill Account, Kennedy Hearing, Create Climate On Capitol Hill for Increasing Cancer Funding

May 3, 1991

FDA, ASCO Meet to Review Drug Approval Endpoints

April 25, 2003